Steven D. Rubin, Director at Entera Bio Ltd. ([ENTX]), bought 5,000 shares at $1.49 ($7K) on 2026-02-12, disclosed to the SEC on 2026-02-17.
Open-market purchase of $7k [ENTX] by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| OPK | BUY | 2024-01-05 | $9K | — | Filing → |
| OPK | BUY | 2023-11-13 | $13K | — | Filing → |
| CDXC | BUY | 2023-05-30 | $10K | — | Filing → |